aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinúria, paroxysmálna - imunosupresíva - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
gavreto
roche registration gmbh - pralsetinib - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
thalidomide lipomed
lipomed gmbh - talidomid - viacnásobný myelóm - imunosupresíva - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
bozilos
egis pharmaceuticals plc, maďarsko - teriflunomid - 59 - immunopraeparata
daruph 111 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 79 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 63 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 55 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 40 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 16 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica